You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IPSS%20Int-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Severe Alcoholic Hepatitis (sAH) Trial in Baltimore (INT-787)

Recruiting
  • Severe Alcoholic Hepatitis (sAH)
  • Baltimore, Maryland
    Mercy Medical Center
Jan 5, 2023

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between

Recruiting
  • Prostate Cancer
  • +5 more
  • grade and compare reported side effects between groups
  • Quebec, Canada
    CHUdeQuebec
Mar 14, 2023

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2022

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    Myelodysplastic Syndrome Trial in Worldwide (Lenalidomide)

    Completed
    • Myelodysplastic Syndrome
    • Centre City, New Jersey
    • +148 more
    Aug 18, 2022

    Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

    Recruiting
    • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
    • Ocala, Florida
    • +3 more
    Jan 30, 2023

    Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

    Active, not recruiting
    • Breast Cancer
    • +10 more
    • Los Angeles, California
    • +7 more
    Jun 21, 2022

    MDS, CMML Trial in Florence (CC-486)

    Recruiting
    • MDS
    • CMML
    • Florence, Italy
      AOU Careggi- University of Florence
    Mar 16, 2021

    Breast Cancer Trial in Ottawa (INT230-6, Saline injection)

    Recruiting
    • Breast Cancer
    • Ottawa, Ontario, Canada
      The Ottawa Hospital Research Institute and Cancer Center
    Nov 9, 2021

    Urinary Tract Infection Trial in Taichung (Nettle and Cranberry complex capsules, Placebo(starch))

    Not yet recruiting
    • Urinary Tract Infection
    • Nettle and Cranberry complex capsules
    • Placebo(starch)
    • Taichung, Taiwan
      Chung Shan Medical University Hospital
    May 19, 2023

    MDS Trial in China, Japan (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
    • +33 more
    Aug 16, 2022

    MDS Trial in France, Germany (N-Plate / romiplostim)

    Completed
    • Myelodysplastic Syndromes
    • N-Plate / romiplostim
    • Annecy, France
    • +35 more
    Sep 7, 2021

    COVID-19 (SARS-CoV-2) in Urine and Semen

    Completed
    • SARS-CoV 2
    • +4 more
    • SARS-CoV 2 RNA PCR Urine
    • +7 more
    • Florence, Tuscany, Italy
      AOU Careggi
    Oct 8, 2021

    Liver Cirrhosis, Biliary Trial in Worldwide (Placebo, Obeticholic Acid (OCA))

    Completed
    Has Results
    • Liver Cirrhosis, Biliary
    • Placebo
    • Obeticholic Acid (OCA)
    • Detroit, Michigan
    • +20 more
    May 28, 2021

    Models of Nutrition From Continuous Glucose Monitors

    Recruiting
    • Diabetes Mellitus, Type 2
    • +3 more
      • Santa Barbara, California
      • +1 more
      Sep 23, 2021

      Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Birmingham, Alabama
      • +27 more
      Jan 20, 2023

      Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Minneapolis (FATE-NK100, Interleukin-2)

      Completed
      • Epithelial Ovarian Cancer
      • +2 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Mar 10, 2021

      Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of

      Active, not recruiting
      • Acute Myeloid Leukemia With Multilineage Dysplasia
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 25, 2022

      MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Luspatercept
      • Epoetin Alfa
      • Concord, California
      • +100 more
      Jul 20, 2023

      HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

      Completed
      • HIV
      • Burkitt's Lymphoma
      • Induction Phase
      • +4 more
      • Aviano (PN), Italy
      • +7 more
      Aug 2, 2022

      MDS Trial in United States (Pracinostat, Azacitidine)

      Terminated
      Has Results
      • Myelodysplastic Syndromes
      • Duarte, California
      • +24 more
      Feb 4, 2022